Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Eosinophilia-Myalgia Syndrome MeSH Descriptor Data 2025


MeSH Heading
Eosinophilia-Myalgia Syndrome
Tree Number(s)
C05.651.290
C10.668.491.050
C15.378.553.231.335
Unique ID
D016603
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D016603
Scope Note
A complex systemic syndrome with inflammatory and autoimmune components that affect the skin, fascia, muscle, nerve, blood vessels, lung, and heart. Diagnostic features generally include EOSINOPHILIA, myalgia severe enough to limit usual activities of daily living, and the absence of coexisting infectious, autoimmune or other conditions that may induce eosinophilia. Biopsy of affected tissue reveals a microangiopathy associated with diffuse inflammation involving connective tissue. (From Spitzer et al., J Rheumatol Suppl 1996 Oct;46:73-9; Blackburn WD, Semin Arthritis Rheum 1997 Jun;26(6):788-93)
Entry Term(s)
Eosinophilia-Myalgia Syndrome, L-Tryptophan-Related
L-Tryptophan-Related Eosinophilia-Myalgia Syndrome
Syndrome, Eosinophilia-Myalgia, L-Tryptophan-Related
Previous Indexing
Eosinophilia/chemically induced (1989-1990)
Muscular Diseases/chemically induced (1990)
Tryptophan/adverse effects (1989-1990)
Public MeSH Note
92
History Note
92
Date Established
1992/01/01
Date of Entry
1991/01/25
Revision Date
2018/06/30
Eosinophilia-Myalgia Syndrome Preferred
Eosinophilia-Myalgia Syndrome, L-Tryptophan-Related Narrower
page delivered in 0.129s